Life Sciences: Regulatory
UK Guide 2025 : UK-wide
Band 2
Email address
[email protected]Contact number
+44 20 7300 7000Chambers Review
Taylor Wessing has an excellent transactional practice built on years of commitment to the sector, advising on collaboration, licensing, corporate and venture capital deals. It has a powerful patent litigation offering acting for generics and also branded manufacturers, which has pioneering experience handling cases involving biosimilar products. The team is also recommended for EPO patent oppositions.
Work Highlights
- Taylor Wessing represented Pfizer in patent revocation proceedings against uniQure in the UK.
Strengths
Provided by Chambers
"The Taylor Wessing team is on top of details and manages to drive deals to closing with efficiency, showing a good understanding of the industry sector and commercial awareness of key deal terms."
"Taylor Wessing have a deep understanding of the life sciences industry. They are adept at handling complex transactions and are effective in negotiations, always prioritising clients."
"Taylor Wessing are highly trusted on complex legal and commercial issues and very strong in general corporate, UK law and life sciences."
"The Taylor Wessing team is on top of details and manages to drive deals to closing with efficiency, showing a good understanding of the industry sector and commercial awareness of key deal terms."
"Taylor Wessing have a deep understanding of the life sciences industry. They are adept at handling complex transactions and are effective in negotiations, always prioritising clients."
"Taylor Wessing are highly trusted on complex legal and commercial issues and very strong in general corporate, UK law and life sciences."
Notable Practitioners
Alison Dennis is called on by leading sector clients to advise them on the compliance of their products with various regulatory regimes and their transactions. She acts for market leaders in biotech, medical devices and pharmaceuticals.
Matthew Royle frequently represents pharmaceutical manufacturers in contentious work regarding patent infringement claims, revocation actions and secondary use SPCs. Prior to his legal career he undertook a doctorate in medical microbiology.
Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and coordinates pan-European litigation strategies.
"Simon is very active and has a strong reputation in life sciences patent litigation."
Andrew Edge is highly regarded for his expertise in M&A and equity capital markets advising pharmaceuticals and biotechnology companies.
"Andrew is a trusted partner. He is highly relationship-driven and provides excellent client service."
"A corporate lawyer with good life science expertise. Andrew clearly knows the space."
Nigel Stoate is renowned for his patent litigation work before UK courts and coordinates Europe-wide disputes strategy. His skill set takes in mechanical and electrical engineering cases as well as disputes concerned with pharmaceuticals.